Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
about
Corticosteroid implants for chronic non-infectious uveitisCorticosteroid implants for chronic non-infectious uveitisUpdates on the Clinical Trials in Diabetic Macular EdemaRole of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implantINTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: PHARMACOKINETIC CONSIDERATIONSMoving Past Anti-VEGF: Novel Therapies for Treating Diabetic RetinopathyDiabetic macular oedema: evidence-based treatment recommendations for Asian countries.Diabetic macular edema: New promising therapies.Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomyEconomic considerations of macular edema therapiesDiabetic macular edema: new trends in management.Diabetic macular edema: therapeutic options.Pharmacotherapy for uveitis: current management and emerging therapy.Review of therapeutic advances in diabetic retinopathy.Pathophysiology and treatment of diabetic retinopathy.Current treatments in diabetic macular oedema: systematic review and meta-analysisFluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema.Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptideLocal therapies for inflammatory eye disease in translation: past, present and futureTreatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant.One-Year Feasibility Study of Replenish MicroPump for Intravitreal Drug Delivery: A Pilot Study.A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case seriesCurrent intravitreal pharmacologic therapies for diabetic macular edema.Case Series Investigating the Efficacy and Safety of Bilateral Fluocinolone Acetonide (ILUVIEN(®)) in Patients with Diabetic Macular EdemaElevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management.Intravitreal Corticosteroids in the Management of Diabetic Macular EdemaDiabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis.Think global--act local: intravitreal drug delivery systems in chronic noninfectious uveitis.The evolving treatment options for diabetic macular edema.Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye.A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluation.Nonbiological pharmacotherapies for the treatment of diabetic macular edema.Fluocinolone acetonide for the treatment of diabetic macular edema.Drug, delivery and devices for diabetic retinopathy (3Ds in DR).Fluocinolone acetonide and its potential in the treatment of chronic diabetic macular edema.Evaluation of extended release brimonidine intravitreal device in normotensive rabbit eyes.Pharmacology of Corticosteroids for Diabetic Macular Edema.New Drugs and New Posterior Delivery Methods in CME.
P2860
Q24186144-ED99DC71-594F-4726-9F27-77BEA1707339Q24198202-3079F3D4-2911-49CF-BD89-DCA20A69D79FQ26767100-220A218E-0F03-4E84-9B17-BB08B7D93BF9Q26775853-4C0623AD-9F85-4B35-AEF8-A1CD74273345Q26782198-7D5CF2DA-56EA-4151-A794-F2875E8FD7A2Q28078199-F4EC9FCB-4FBC-4025-99E5-EF4B78CE4182Q30101045-6F8B7A77-D376-461F-88A3-3A2A64596781Q30415630-1EC6A7A4-8073-4DF6-897F-43161F10BC41Q33705718-E71E2EA2-81B5-42E7-8CD6-252ABA7FC0A6Q33878122-163D9173-57F6-4208-ACE1-7D445AC54C86Q34091784-69524BD7-C9A8-4317-93BA-3DC91AFD4769Q34185374-C7009695-1133-4DDB-9EE1-79003B2551A1Q34274075-CA7643CB-9CE6-48C1-8FE7-2B4F1D57DC02Q34475449-766046C7-0DA9-4FDE-B972-D4DAA216B192Q34528134-6D094BB3-CD1F-45AA-88E9-4B458C12FA71Q34606190-D4E1B51A-9CD2-4C44-B7E8-8410766EF819Q34758061-9CCDBA49-4DA7-4287-9915-2B2AFB4E50F3Q34816580-B41D0272-39C1-44AE-991F-72243B51D083Q34892662-EEB40DE5-3D44-4743-ADD2-8E85B52B5538Q35128723-F4DF2DD8-19AB-4E99-AC40-A22D177596C9Q35167647-AF019959-8DB8-4985-B937-216466B40BF9Q35592903-54945E8B-CF71-435C-930D-75633A9DF6DFQ35650268-FE1CA917-AC65-45E6-B83C-5650B2EF9481Q35925938-54DCC429-6964-4D41-9F6A-B8791DBDEAB2Q36013578-67E679E1-EE76-478C-8361-F9FB57E91CEEQ37287831-344F500F-A689-4A35-8D62-C5F61E1AC3A2Q37477129-67B1A758-11A6-4DB0-8488-77EECC7F983FQ37845396-5CB9CEF1-3F24-4D4E-945C-A023C16C3EC2Q38069093-A460D5CA-C154-4BDF-A223-D45248CCA8F7Q38150855-BBAADA9D-D722-4F6F-8385-EB962BD8380CQ38211433-B74E0364-A48E-48AC-AD0B-8AC6185B8A4DQ38250116-43DEF8DD-3201-4E39-A1DA-69C763880C98Q38494605-42DBEF64-EABB-4293-90AE-1D1A74603E2CQ38622256-061C1F84-452A-4365-B2A1-B72FA57F321BQ38648612-A6C52996-FE9F-4A25-A900-83A042E97BF2Q38832441-60D18FB9-6770-4707-92A1-FE31AC7F4806Q41236033-896B040C-50FE-4055-82B3-8469B40814C9Q47653427-0BCA40BA-CECA-4CB4-946C-41E924A5131EQ47753853-7AEC20D4-7B79-4360-A0E9-C2F0E9E83FA8Q50073381-0C9025B1-B8FF-48E8-BA71-F8A3797AE5A3
P2860
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
@ast
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
@en
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
@nl
type
label
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
@ast
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
@en
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
@nl
prefLabel
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
@ast
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
@en
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
@nl
P2093
P1433
P1476
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
@en
P2093
Barry Kapik
David M Brown
Famous Study Group
Frances Kane
Gulnar Hafiz
Kathleen Billman
Leonard Feiner
Miguel Busquets
Nelson Sabates
P304
P356
10.1016/J.OPHTHA.2009.11.024
P577
2010-03-03T00:00:00Z